#antibodies

Study findings identify a potential marker that could help identify people at high risk of developing long COVID.

Antibodies crossed the placenta, likely conferring some protection for newborns immediately after birth.

These datasets may measure a patient’s response to a new COVID-19 variant or to cancer-causing viruses like human papillomavirus (HPV).

A molecular decoy that neutralizes the SARS-CoV-2 virus by preventing it from latching onto cells protected mice against COVID-19.

The findings provide a basis for future studies of the immune system’s role in longevity.

Researchers discover antibodies to block common respiratory viruses that put bone marrow and stem cell transplant patients at risk.

Fred Hutch study suggests certain immune cells are the source of antibodies that attack donated organs.

NIAID-supported research sheds light on why healthy people of the same age respond differently to vaccines.

A single vaccine dose delivered to nose aims to protect children and adults against COVID.

A mathematical technique called matrix completion could speed up the development of vaccines for flu and COVID-19 variants.

Extra vaccine doses, monoclonal antibodies and antivirals can help prevent severe illness.

Two treatment approaches using donor or engineered NK cells led to remission in people with lymphoma and leukemia.

Researchers urge survivors and their doctors to monitor heart health.

A new type of treatment uses antibodies to deliver cancer-fighting drugs directly to tumors.

Researchers showed that B cells evolve after COVID-19 vaccination to help improve protection against SARS-CoV-2 over time.

New discoveries may show a way to save bone marrow cells and blood stem cells following chemotherapy.